AstraZeneca PLC Stock Target Price and Analyst Consensus
| AZN Stock | USD 68.36 0.17 0.25% |
The current analyst and expert consensus on AstraZeneca PLC is Strong Buy, with 7 strong buy opinions. The current projected AstraZeneca PLC target price consensus is 83.71 with 13 analyst opinions. The most common way AstraZeneca PLC ADR analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview AstraZeneca PLC executives and customers to further validate their buy or sell advice. AstraZeneca PLC buy-or-sell recommendation module provides average expert sentiment on the projected AstraZeneca PLC ADR target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on AstraZeneca PLC to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
Lowest Forecast 76.18 | Highest Forecast 92.92 | Target Price 83.71 |
AstraZeneca |
It's important to approach AstraZeneca PLC's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize AstraZeneca PLC price targets
AstraZeneca PLC's stock target price is an estimate of its future price, usually made by analysts. Using AstraZeneca PLC's target price to determine if it is a suitable investment can be done through the following steps:- Look at AstraZeneca PLC's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if AstraZeneca PLC's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional AstraZeneca PLC Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of AstraZeneca PLC is a key component of AstraZeneca PLC valuation and have some predictive power on the future returns of a AstraZeneca PLC.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of AstraZeneca PLC's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | FinTech Invested over 70 shares | |
 | Manufacturing Invested over 40 shares | |
 | Investor Favorites Invested over 200 shares | |
 | Banking Invested over 30 shares | |
 | Social Domain Invested few shares | |
 | Driverless Cars Invested over 200 shares | |
 | Macroaxis Index Invested few shares | |
 | Automobiles and Trucks Invested over 200 shares | |
Check out Macroaxis Advice on AstraZeneca PLC to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. Note that the AstraZeneca PLC ADR information on this page should be used as a complementary analysis to other AstraZeneca PLC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Complementary Tools for AstraZeneca Stock analysis
When running AstraZeneca PLC's price analysis, check to measure AstraZeneca PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AstraZeneca PLC is operating at the current time. Most of AstraZeneca PLC's value examination focuses on studying past and present price action to predict the probability of AstraZeneca PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AstraZeneca PLC's price. Additionally, you may evaluate how the addition of AstraZeneca PLC to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
The data published in AstraZeneca PLC's official financial statements usually reflect AstraZeneca PLC's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of AstraZeneca PLC ADR. For example, before you start analyzing numbers published by AstraZeneca accountants, it's critical to develop an understanding of what AstraZeneca PLC's liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of AstraZeneca PLC's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, AstraZeneca PLC's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in AstraZeneca PLC's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of AstraZeneca PLC ADR. Please utilize our Beneish M Score to check the likelihood of AstraZeneca PLC's management manipulating its earnings.